ENDONOVO THERAPEUTICS, INC. Common Stock Shares Outstanding

Quick Answer

ENDONOVO THERAPEUTICS, INC. reported Common Stock Shares Outstanding of 213.23 million shares for the year ending 2022.

  • ENDONOVO THERAPEUTICS, INC. showed an increase of +186.2% in Common Stock Shares Outstanding from 2021 to 2022.
  • This data is from ENDONOVO THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on April 17, 2023.
  • XBRL data for this metric is available from 2014 to 2022 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q4 2012: 53.69 million shares | Q3 2013: 75.83 million shares | Q3 2015: 101.29 million shares | Q3 2015: 101.95 million shares | Q2 2016: 117.90 million shares | Q3 2016: 124.77 million shares | Q1 2017: 225.68 million shares | Q2 2017: 244.17 million shares | Q3 2017: 284.06 million shares | Q1 2018: 337.96 million shares | Q2 2018: 356.27 million shares | Q3 2018: 381.38 million shares | Q1 2019: 516.77 million shares | Q2 2019: 730.56 million shares | Q3 2019: 834.28 million shares | Q1 2020: 7.21 million shares | Q2 2020: 7.21 million shares | Q3 2020: 17.30 million shares | Q1 2021: 51.52 million shares | Q2 2021: 60.66 million shares | Q3 2021: 69.19 million shares | Q1 2022: 81.33 million shares | Q2 2022: 150.43 million shares | Q3 2022: 159.23 million shares | Q4 2022: 213.23 million shares | Q1 2023: 270.29 million shares | Q2 2023: 278.80 million shares | Q3 2023: 318.75 million shares.
  • Over the full 11 years of available data (2014 to 2022), ENDONOVO THERAPEUTICS, INC.'s Common Stock Shares Outstanding has grown by 161.9%.
  • Historical annual values: Fiscal year 2022: 213.23 million shares | Fiscal year 2021: 74.50 million shares | Fiscal year 2020: 24.54 million shares | Fiscal year 2019: 1.19 million shares | Fiscal year 2018: 431,063 shares | Fiscal year 2017: 316.95 million shares | Fiscal year 2016: 134.34 million shares | Fiscal year 2016: 108.03 million shares | Fiscal year 2015: 104.80 million shares | Fiscal year 2015: 103.29 million shares | Fiscal year 2014: 81.43 million shares.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: